blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3328358

EP3328358 - CONCENTRATE CONTAINING ALPROSTADIL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.09.2023
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  21.10.2022
FormerGrant of patent is intended
Status updated on  20.07.2022
FormerExamination is in progress
Status updated on  24.07.2019
FormerRequest for examination was made
Status updated on  04.05.2018
FormerThe international publication has been made
Status updated on  03.02.2017
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): IT
published on 26.06.2024 [2024/26]
Applicant(s)For all designated states
Gebro Holding GmbH
Bahnhofbichl 13
6391 Fieberbrunn / AT
[2018/23]
Inventor(s)01 / HESSE, Ernst
Reitliftweg 18
6391 Fieberbrunn / AT
02 / HANSBAUER, Bernhard
Gemeindeweg 5
5061 Elsbethen-Glasenbach / AT
03 / HÄUSLER, Franz
Gabelsbergerstrasse 1
83435 Bad Reichenhall / DE
 [2018/23]
Representative(s)Wildhack & Jellinek Patentanwälte
Patentanwälte OG
Landstraßer Hauptstraße 50
1030 Wien / AT
[N/P]
Former [2022/47]Wildhack & Jellinek
Patentanwälte OG
Landstraßer Hauptstraße 50
1030 Wien / AT
Former [2018/23]Wildhack & Jellinek
Patentanwälte
Landstraßer Hauptstraße 50
1030 Wien / AT
Application number, filing date16759666.725.07.2016
[2018/23]
WO2016AT60020
Priority number, dateAT2015005066627.07.2015         Original published format: AT 506662015
[2018/23]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2017015692
Date:02.02.2017
Language:DE
[2017/05]
Type: A1 Application with search report 
No.:EP3328358
Date:06.06.2018
Language:DE
The application published by WIPO in one of the EPO official languages on 02.02.2017 takes the place of the publication of the European patent application.
[2018/23]
Type: B1 Patent specification 
No.:EP3328358
Date:23.11.2022
Language:DE
[2022/47]
Search report(s)International search report - published on:EP02.02.2017
ClassificationIPC:A61K31/5575, A61K9/00, A61K47/10, A61K47/12, A61K9/08, A61P9/00
[2022/31]
CPC:
A61K9/0019 (EP,AT); A61K31/5575 (EP,AT); A61K47/10 (EP,AT);
A61K47/12 (EP); A61K9/08 (EP,AT)
Former IPC [2018/23]A61K9/00, A61K47/10, A61K47/12, A61K9/08, A61K31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/23]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:KONZENTRAT ENTHALTEND ALPROSTADIL[2018/23]
English:CONCENTRATE CONTAINING ALPROSTADIL[2018/23]
French:CONCENTRÉ CONTENANT DE L'ALPROSTADIL[2018/23]
Entry into regional phase31.01.2018National basic fee paid 
31.01.2018Designation fee(s) paid 
31.01.2018Examination fee paid 
Examination procedure24.05.2017Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.01.2018Examination requested  [2018/23]
31.01.2018Date on which the examining division has become responsible
07.06.2018Amendment by applicant (claims and/or description)
29.07.2019Despatch of a communication from the examining division (Time limit: M06)
06.02.2020Reply to a communication from the examining division
14.10.2020Despatch of a communication from the examining division (Time limit: M04)
18.12.2020Reply to a communication from the examining division
21.07.2022Communication of intention to grant the patent
14.10.2022Fee for grant paid
14.10.2022Fee for publishing/printing paid
14.10.2022Receipt of the translation of the claim(s)
Opposition(s)24.08.2023No opposition filed within time limit [2023/44]
Fees paidRenewal fee
23.07.2018Renewal fee patent year 03
05.07.2019Renewal fee patent year 04
15.07.2020Renewal fee patent year 05
27.07.2021Renewal fee patent year 06
25.07.2022Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL23.11.2022
CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
IT23.11.2022
LT23.11.2022
LV23.11.2022
MC23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SI23.11.2022
SK23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
GB25.07.2023
LU25.07.2023
BE31.07.2023
CH31.07.2023
FR31.07.2023
[2024/26]
Former [2024/24]AL23.11.2022
CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
MC23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SI23.11.2022
SK23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
GB25.07.2023
LU25.07.2023
BE31.07.2023
CH31.07.2023
FR31.07.2023
Former [2024/18]AL23.11.2022
CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
MC23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SI23.11.2022
SK23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
LU25.07.2023
Former [2024/14]AL23.11.2022
CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
MC23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SI23.11.2022
SK23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/51]AL23.11.2022
CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SI23.11.2022
SK23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/38]AL23.11.2022
CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SK23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/37]AL23.11.2022
CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/35]CZ23.11.2022
DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/33]DK23.11.2022
ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
SM23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/29]ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
NL23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/26]ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
PL23.11.2022
RS23.11.2022
SE23.11.2022
NO23.02.2023
GR24.02.2023
IS23.03.2023
PT23.03.2023
Former [2023/24]ES23.11.2022
FI23.11.2022
HR23.11.2022
LT23.11.2022
LV23.11.2022
SE23.11.2022
NO23.02.2023
GR24.02.2023
PT23.03.2023
Former [2023/23]ES23.11.2022
FI23.11.2022
LT23.11.2022
LV23.11.2022
SE23.11.2022
NO23.02.2023
GR24.02.2023
PT23.03.2023
Former [2023/22]ES23.11.2022
FI23.11.2022
LT23.11.2022
SE23.11.2022
NO23.02.2023
PT23.03.2023
Former [2023/20]LT23.11.2022
NO23.02.2023
Cited inInternational search[X]EP0407148  (GREEN CROSS CORP [JP], et al) [X] 1,2,7,14-16,18,19,24,30,31 * page 2, paragraph 1; examples 1-2 *;
 [X]WO9511683  (UPJOHN CO [US], et al) [X] 1-3,5,7-11,15,16,18,19,27,31 * claims 1-10 *;
 [XI]CN102048687  (NORTH CHINA PHARMACEUTICAL GROUP CORP) [X] 1-4,7-9,18,27,30,31 * the whole document *[I] 6,12,13,17,20-23,25,26,28,29
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.